Inequalities in pharmacologic treatment of spasticity in Sweden – health economic consequences of closing the treatment gap

Abstract Background The Swedish Healthcare Act states that patients should have equal access to healthcare. This study addresses at how this translates to pharmacological treatment of adult spasticity, including injections with botulinum toxin A (BoNT-A) and pumps for intrathecal baclofen (ITB). To...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Annabelle Forsmark, Linda Rosengren, Per Ertzgaard
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-02-01
coleção:	Health Economics Review
Assuntos:	Botulinum toxins Baclofen Muscle spasticity Treatment Access to health care Health care costs
Acesso em linha:	https://doi.org/10.1186/s13561-020-0261-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!